CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE(-/-) mice.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cardiovascular Research

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cvr/cvs330PMID 23118130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4

  2011cited by this paper
• A Novel Mechanism of &ggr;/&dgr; T-Lymphocyte and Endothelial Activation by Shear Stress: The Role of Ecto-ATP Synthase &bgr; Chain

  2011cited by this paper
• The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses

  2011cited by this paper
• Selektive Kostimulationsblockade

  2010influential reference
• Genetic polymorphism of methylenetetrahydrofolate reductase G1793A, hyperhomocysteinemia, and folate deficiency correlate with ulcerative colitis in central China

  2010cited by this paper
• Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice.

  2009cited by this paper
• CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

  2009cited by this paper
• Immune and inflammatory mechanisms of atherosclerosis (*).

  2009cited by this paper
• Neue Option in der Behandlung der rheumatoiden Arthritis: Abatacept, ein selektiver Modulator der T-Zell-Kostimulation

  2009cited by this paper
• Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE 2 / 2 mice

  2009cited by this paper
• TCR/CD3 mediated stop-signal is decoupled in T-cells from Ctla4 deficient mice.

  2008cited by this paper
• T cells in arteritis and atherosclerosis

  2008cited by this paper
• [CTLA4-Ig (abatacept)].

  2007cited by this paper
• Exploring the specificity of the PI3K family inhibitor LY294002.

  2007cited by this paper
• Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy.

  2006cited by this paper
• A molecular perspective of CTLA-4 function.

  2006influential reference
• The Proatherogenic Role of T Cells Requires Cell Division and Is Dependent on the Stage of the Disease

  2005cited by this paper
• Exocytosis of CTLA-4 Is Dependent on Phospholipase D and ADP Ribosylation Factor-1 and Stimulated during Activation of Regulatory T Cells1

  2005cited by this paper
• B7-1/B7-2 Costimulation Regulates Plaque Antigen–Specific T-Cell Responses and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice

  2004cited by this paper
• Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.

  2004cited by this paper
• Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

  2003cited by this paper
• Oxidant stress mechanism of homocysteine potentiating Con A-induced proliferation in murine splenic T lymphocytes.

  2002cited by this paper
• Inflammation and immune responses in atherosclerosis.

  2002cited by this paper
• THE TWO-SIGNAL MODEL OF T-CELL ACTIVATION AFTER 30 YEARS

  2002cited by this paper
• CD28-dependent Activation of Protein Kinase B/Akt Blocks Fas-mediated Apoptosis by Preventing Death-inducing Signaling Complex Assembly

  2002cited by this paper
• Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study.

  2002cited by this paper
• Structural mechanisms of costimulation

  2002cited by this paper
• Mechanism of Action of Combined Short-Term CTLA4Ig and Anti-CD40 Ligand in Murine Systemic Lupus Erythematosus1

  2002cited by this paper
• Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines

  2001cited by this paper
• Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.

  2001cited by this paper
• Cytotoxic T Lymphocyte Antigen 4 and CD28 Modulate Cell Surface Raft Expression in Their Regulation of T Cell Function

  2001cited by this paper
• EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts.

  2000cited by this paper
• Regulation of Cell Surface Expression of CTLA-4 by Secretion of CTLA-4-Containing Lysosomes Upon Activation of CD4+ T Cells1

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation.

  1999cited by this paper
• Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2.

  1999cited by this paper
• Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Blockade Accelerates the Acute Rejection of Cardiac Allografts in CD28-deficient Mice: CTLA4 Can Function Independently of CD28

  1998cited by this paper
• CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma.

  1998cited by this paper
• Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression.

  1997cited by this paper
• Prevention and amelioration of collagen‐induced arthritis by blockade of the CD28 co‐stimulatory pathway: requirement for both B7‐1 and B7‐2

  1996cited by this paper
• Regulation of surface and intracellular expression of CTLA4 on mouse T cells.

  1996influential reference
• The critical role of CD28 signalling in the prevention of human T-cell anergy.

  1995cited by this paper
• CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

  1995cited by this paper
• Two-signal model for T-cell activation: molecular mechanisms.

  1993cited by this paper
• Differential T cell costimulatory requirements in CD28-deficient mice.

  1993cited by this paper
• CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

  1989cited by this paper

• Immune Checkpoint Inhibitors are Associated with Peripheral Artery Disease in Cancer Patients.

  2026cites this paper
• MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives.

  2025cites this paper
• T cells in cardiac health and disease

  2025cites this paper
• Lactate Metabolism and Lactylation Modification: New Opportunities and Challenges in Cardiovascular Disease

  2025cites this paper
• Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studies.

  2025cites this paper
• Immunomodulation for accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.

  2025cites this paper
• Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management

  2025cites this paper
• Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockade

  2024cites this paper
• Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression

  2024cites this paper
• Inhibition of CTLA-4 accelerates atherosclerosis in hyperlipidemic mice by modulating the Th1/Th2 balance via the NF-κB signaling pathway

  2024cites this paper
• Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy

  2024cites this paper
• Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall

  2024cites this paper
• Homocysteine, hyperhomocysteinemia and H-type hypertension.

  2024cites this paper
• Coronary artery disease-associated immune gene RBP1 and its pan-cancer analysis

  2023cites this paper
• Immunotherapy-Associated Atherosclerosis: A Comprehensive Review of Recent Findings and Implications for Future Research

  2023cites this paper
• Impact of Immunity on Coronary Artery Disease: An Updated Pathogenic Interplay and Potential Therapeutic Strategies

  2023cites this paper
• Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study

  2023cites this paper
• Recent advances in shikonin for the treatment of immune-related diseases: Anti-inflammatory and immunomodulatory mechanisms.

  2023cites this paper
• An Increased Understanding of the Association Between Atherosclerosis and Immune Checkpoint Inhibitors

  2023cites this paper
• Role of inflammation and immune response in atherosclerosis: Mechanisms, modulations, and therapeutic targets.

  2023cites this paper
• Advances in immunotherapy modalities for atherosclerosis

  2023cites this paper
• Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis

  2022cites this paper
• Atherosclerosis With Immune Checkpoint Inhibitor Therapy

  2022cites this paper
• Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost

  2022cites this paper
• Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review

  2022cites this paper
• Immune Checkpoint Therapies and Atherosclerosis: Mechanisms and Clinical Implications: JACC State-of-the-Art Review.

  2022cites this paper
• Targeting inflammation in atherosclerosis — from experimental insights to the clinic

  2021cites this paper
• Recent Advances on the Role and Therapeutic Potential of Regulatory T Cells in Atherosclerosis

  2021cites this paper
• Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis

  2021cites this paper
• Immune-based therapies in cardiovascular and metabolic diseases: past, present and future

  2021cites this paper
• Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.

  2021cites this paper
• Endothelial dysfunction sustains immune response in atherosclerosis: potential cause for ineffectiveness of prevailing drugs

  2021cites this paper
• Mitochondrial Contact Sites in Inflammation-Induced Cardiovascular Disease

  2020cites this paper
• Neue onkologische Therapien und ihre kardiovaskulären Risiken

  2020cites this paper
• New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity

  2020cites this paper
• Homocysteine concentration and adenosine A2A receptor production by peripheral blood mononuclear cells in coronary artery disease patients

  2020cites this paper
• Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice

  2020cites this paper
• Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review

  2020cites this paper
• Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting

  2020cites this paper
• Dendrobine attenuates gestational diabetes mellitus in mice by inhibiting Th17 cells

  2020cites this paper
• Novel human immunomodulatory T cell receptors and their double-edged potential in autoimmunity, cardiovascular disease and cancer

  2020cites this paper
• Decreased autophagy of vascular smooth muscle cells was involved in hyperhomocysteinemia‐induced vascular ageing

  2020cites this paper
• Intermedin1-53 Ameliorates Homocysteine-Promoted Atherosclerotic Calcification by Inhibiting Endoplasmic Reticulum Stress

  2019cites this paper
• T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword

  2019cites this paper
• Perilipin 5 deficiency promotes atherosclerosis progression through accelerating inflammation, apoptosis, and oxidative stress

  2019cites this paper
• Deficiency of programmed cell death 4 affects the balance of T cell subsets in hyperlipidemic mice.

  2019cites this paper
• Immunotherapy for cardiovascular disease.

  2019cites this paper
• Homocysteine and psoriasis

  2019cites this paper
• Shikonin attenuates hyperhomocysteinemia-induced CD4+ T cell inflammatory activation and atherosclerosis in ApoE−/− mice by metabolic suppression

  2019cites this paper
• Full Issue PDF

  2019cites this paper
• Cardiotoxicity from immune checkpoint inhibitors

  2019cites this paper
• Impact of B-Cell-Targeted Therapies on Cardiovascular Disease.

  2019cites this paper
• ATVB IN FOCUS: Clinically Available Immunotherapies: Expected Impact on Cardiovascular Disease

  2019cites this paper
• 2016 Jeffrey M. Hoeg Award Lecture: Immune Checkpoints in Atherosclerosis Toward Immunotherapy for Atheroprotection

  2018cites this paper
• PKM2-dependent metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis

  2018cites this paper
• GSNOR modulates hyperhomocysteinemia-induced T cell activation and atherosclerosis by switching Akt S-nitrosylation to phosphorylation

  2018cites this paper
• Exploring immune checkpoints as potential therapeutic targets in atherosclerosis

  2018cites this paper
• Identification of homocysteine-suppressive mitochondrial ETC complex genes and tissue expression profile – Novel hypothesis establishment

  2018cites this paper
• Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury

  2018cites this paper
• Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study

  2018cites this paper
• T cell costimulation blockade blunts pressure overload-induced heart failure

  2017cites this paper
• Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension.

  2017cites this paper
• Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets

  2017cites this paper
• ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis

  2017cites this paper
• Immune-Mediated Accelerated Atherosclerosis

  2017cites this paper
• Readapting the adaptive immune response – therapeutic strategies for atherosclerosis

  2017cites this paper
• Plin5 deficiency promotes atherosclerosis progression through accelerating inflammation, apoptosis and oxidative stress.

  2017cites this paper
• Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis

  2017cites this paper
• Homocysteine Activates B Cells via Regulating PKM2-Dependent Metabolic Reprogramming

  2017cites this paper
• Readapting the adaptive immune response – therapeutic strategies for atherosclerosis

  2017cites this paper
• Involvement of histone methylation in macrophage apoptosis and unstable plaque formation in methionine‐induced hyperhomocysteinemic ApoE−/− mice

  2017cites this paper
• Homocysteine activates T cells by enhancing endoplasmic reticulum-mitochondria coupling and increasing mitochondrial respiration

  2016cites this paper
• Overexpression of Cytotoxic T-Lymphocyte–Associated Antigen-4 Prevents Atherosclerosis in Mice

  2016cites this paper
• Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?

  2016cites this paper
• Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells.

  2016cites this paper
• Energy metabolism of T-lymphocytes and its biological significance

  2016cites this paper
• An inflammatory link in atherosclerosis and obesity

  2015cites this paper
• Regulatory T cells and tolerogenic dendritic cells as critical immune modulators in atherogenesis.

  2015cites this paper
• Inflammation als Pathomechanismus in Atherosklerose und Adipositas

  2015cites this paper
• Regulation of atherosclerotic plaque inflammation

  2015cites this paper
• Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis

  2015cites this paper
• Cardiovascular research as a forum for publications from China: present, past, and future.

  2014cites this paper
• The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis

  2014cites this paper
• The influence of innate and adaptive immune responses on atherosclerosis.

  2014cites this paper
• Adaptive (T and B Cells) Immunity and Control by Dendritic Cells in Atherosclerosis

  2014cites this paper
• Protein kinase C isoforms in atherosclerosis: pro- or anti-inflammatory?

  2014cites this paper
• Effect of homocysteine on mitochondrial membrane potential of human umbilical vein endothelial cells

  2013cites this paper
• Regulating atherosclerosis via costimulatory and coinhibitory pathways

  2013cites this paper